Neurochemistry of response inhibition and interference in gambling disorder: A preliminary study of γ-aminobutyric acid (GABA+) and glutamate-glutamine (Glx)
Research output: Contribution to journal › Article › peer-review
Standard Standard
In: CNS Spectrums, Vol. 27, No. 4, 08.2022, p. 475-485.
Research output: Contribution to journal › Article › peer-review
HarvardHarvard
APA
CBE
MLA
VancouverVancouver
Author
RIS
TY - JOUR
T1 - Neurochemistry of response inhibition and interference in gambling disorder
T2 - A preliminary study of γ-aminobutyric acid (GABA+) and glutamate-glutamine (Glx)
AU - Weidacker, Kathrin
AU - Johnston, Stephen J
AU - Mullins, Paul G.
AU - Boy, Frederic
AU - Dymond, Simon
PY - 2022/8
Y1 - 2022/8
N2 - BackgroundNeurobehavioral research on the role of impulsivity in gambling disorder (GD) has produced heterogeneous findings. Impulsivity is multifaceted with different experimental tasks measuring different subprocesses, such as response inhibition and distractor interference. Little is known about the neurochemistry of inhibition and interference in GD.MethodsWe investigated inhibition with the stop signal task (SST) and interference with the Eriksen Flanker task, and related performance to metabolite levels in individuals with and without GD. We employed magnetic resonance spectroscopy (MRS) to record glutamate–glutamine (Glx/Cr) and inhibitory, γ-aminobutyric acid (GABA+/Cr) levels in the dorsal ACC (dACC), right dorsolateral prefrontal cortex (dlPFC), and an occipital control voxel.ResultsWe found slower processing of complex stimuli in the Flanker task in GD (P < .001, η2p = 0.78), and no group differences in SST performance. Levels of dACC Glx/Cr and frequency of incongruent errors were correlated positively in GD only (r = 0.92, P = .001). Larger positive correlations were found for those with GD between dACC GABA+/Cr and SST Go error response times (z = 2.83, P = .004), as well as between dACC Glx/Cr and frequency of Go errors (z = 2.23, P = .03), indicating general Glx-related error processing deficits. Both groups expressed equivalent positive correlations between posterror slowing and Glx/Cr in the right dlPFC (GD: r = 0.74, P = .02; non-GD: r = .71, P = .01).ConclusionInhibition and interference impairments are reflected in dACC baseline metabolite levels and error processing deficits in GD.
AB - BackgroundNeurobehavioral research on the role of impulsivity in gambling disorder (GD) has produced heterogeneous findings. Impulsivity is multifaceted with different experimental tasks measuring different subprocesses, such as response inhibition and distractor interference. Little is known about the neurochemistry of inhibition and interference in GD.MethodsWe investigated inhibition with the stop signal task (SST) and interference with the Eriksen Flanker task, and related performance to metabolite levels in individuals with and without GD. We employed magnetic resonance spectroscopy (MRS) to record glutamate–glutamine (Glx/Cr) and inhibitory, γ-aminobutyric acid (GABA+/Cr) levels in the dorsal ACC (dACC), right dorsolateral prefrontal cortex (dlPFC), and an occipital control voxel.ResultsWe found slower processing of complex stimuli in the Flanker task in GD (P < .001, η2p = 0.78), and no group differences in SST performance. Levels of dACC Glx/Cr and frequency of incongruent errors were correlated positively in GD only (r = 0.92, P = .001). Larger positive correlations were found for those with GD between dACC GABA+/Cr and SST Go error response times (z = 2.83, P = .004), as well as between dACC Glx/Cr and frequency of Go errors (z = 2.23, P = .03), indicating general Glx-related error processing deficits. Both groups expressed equivalent positive correlations between posterror slowing and Glx/Cr in the right dlPFC (GD: r = 0.74, P = .02; non-GD: r = .71, P = .01).ConclusionInhibition and interference impairments are reflected in dACC baseline metabolite levels and error processing deficits in GD.
KW - GABA
KW - Gambling
KW - MRS
KW - response inhibition
KW - response interference
U2 - 10.1017/S1092852921000316
DO - 10.1017/S1092852921000316
M3 - Article
C2 - 33752778
VL - 27
SP - 475
EP - 485
JO - CNS Spectrums
JF - CNS Spectrums
SN - 1092-8529
IS - 4
ER -